We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| 4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 16.36 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDDDD
RNS Number : 1968Z
4d Pharma PLC
10 March 2017
4D pharma plc
(the "Company" or "4D")
Notification of Major Interest in Shares
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics announces the following notification of major interest in shares, notified to the Company on the following dates:
19 February 2016
12 April 2016
27 April 2016
13 June 2016
25 July 2016
The full details are shown below.
For further information please contact:
4D + 44 (0)113 895 0130 Duncan Peyton, Chief Executive Officer Zeus Capital Limited - Nomad and Broker Dan Bate +44 (0) 161 831 1512 Dominic Wilson +44 (0) 203 829 5000
About 4D
Founded in February 2014, 4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 13 preclinical programmes, covering disease areas such as rheumatoid arthritis, multiple sclerosis and cancer, and is currently conducting subject trials in Irritable Bowel Syndrome and Paediatric Crohn's Disease. The programmes in Paediatric Ulcerative Colitis and Paediatric Crohn's Disease have both been granted Orphan Drug Status by the FDA.
Hot Features
Premium
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or 4D Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
------------------------------------------------------------ -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -------------------------------
Other (please
specify):
---------------------------------------------------------- -------------------------------
3. Full name of person(s) Woodford Investment Management
subject to the LLP (Woodford)
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------
4. Full name of shareholder(s) Clients of Woodford
(if different from 3.):(iv)
----------------------------------------------------------- --------------------------------
5. Date of the transaction 18.02.2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------
6. Date on which issuer 19.02.2016
notified:
----------------------------------------------------------- --------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 25%
----------------------------------------------------------- --------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
GB00BJL5BR07 16,016,637 16,016,637 16,305,108 16,305,108 25%
--------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
16,305,108 25%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Woodford, as Investment Manager
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Akpene Akonou
------------------------------------------------------------- --------------
15. Contact telephone number: 01865 809024
------------------------------------------------------------- --------------
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or 4D Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
------------------------------------------------------------ -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -------------------------------
Other (please
specify):
---------------------------------------------------------- -------------------------------
3. Full name of person(s) Woodford Investment Management
subject to the LLP (Woodford)
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------
4. Full name of shareholder(s) Clients of Woodford
(if different from 3.):(iv)
----------------------------------------------------------- --------------------------------
5. Date of the transaction 11.04.2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------
6. Date on which issuer 12.04.2016
notified:
----------------------------------------------------------- --------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 26%
----------------------------------------------------------- --------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
GB00BJL5BR07 16,743,704 16,743,704 17,040,232 17,040,232 26%
--------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
17,040,232 26%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Woodford, as Investment Manager
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Akpene Akonou
------------------------------------------------------------- --------------
15. Contact telephone number: 01865 809024
------------------------------------------------------------- --------------
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or 4D Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ---------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights x
------------------------------------------------------------------------------------------------
Other (please Change to a client arrangement in
specify): respect of voting rights. No sale
or purchase of shares.
---------------------------------------------------------- ------------------------------------
3. Full name of person(s) Woodford Investment Management
subject to the LLP (Woodford)
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------------------
4. Full name of shareholder(s) Clients of Woodford
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------------------
5. Date of the transaction 25.04.2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------------------
6. Date on which issuer 27.04.2016
notified:
----------------------------------------------------------- ---------------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 26%
----------------------------------------------------------- ---------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
GB00BJL5BR07 17,314,218 17,314,218 17,314,218 16,500,948 25%
--------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
16,500,948 25%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Woodford, as Investment Manager
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Akpene Akonou
------------------------------------------------------------- --------------
15. Contact telephone number: 01865 809024
------------------------------------------------------------- --------------
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or 4D Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
------------------------------------------------------------ -------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -------------------------------
Other (please
specify):
---------------------------------------------------------- -------------------------------
3. Full name of person(s) Woodford Investment Management
subject to the LLP (Woodford)
notification obligation:
(iii)
----------------------------------------------------------- --------------------------------
4. Full name of shareholder(s) Clients of Woodford
(if different from 3.):(iv)
----------------------------------------------------------- --------------------------------
5. Date of the transaction 10.06.2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- --------------------------------
6. Date on which issuer 13.06.2016
notified:
----------------------------------------------------------- --------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 26%
----------------------------------------------------------- --------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ------------------------------------------------ ------------------------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ----------------------- ----------------------- --------------------- ---------------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------------- ------------------- --------------------- --------------------- ----------- ------------ -----------
GB00BJL5BR07 16,821,106 16,821,106 16,872,073 16,872,073 26.01%
----------------------- ----------------------- --------------------- --------------------- ----------- ------------ -----------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- --------------------- ---------------------------------------------- ------------------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- --------------------- --------------------- ----------------------- ------------------------------------ -----------------------
Nominal Delta
--------------- --------------------- --------------------- ----------------------- ------------------------------------ ------------ ---------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------------------------- ----------------------------------------------------------------------------------
16,872,073 26.01%
----------------------------------------------------------------- ----------------------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
Woodford, as Investment Manager
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- --------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- --------------
13. Additional information:
------------------------------------------------------------- --------------
14. Contact name: Akpene Akonou
------------------------------------------------------------- --------------
15. Contact telephone number: 01865 809024
------------------------------------------------------------- --------------
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or 4d pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
---------------------------------------------------------- ---------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------- --------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
----------------------------------------------------------- --------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
----------------------------------------------------------- --------------------------------
An event changing the breakdown of voting rights
----------------------------------------------------------- --------------------------------
Other (please
specify):
--------------------------------------------------------- --------------------------------
3. Full name of person(s) Woodford Investment Management
subject to the LLP
notification obligation:
(iii)
---------------------------------------------------------- ---------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
---------------------------------------------------------- ---------------------------------
5. Date of the transaction
and date on
which the threshold is
crossed or
reached: (v) 22/07/2016
---------------------------------------------------------- ---------------------------------
6. Date on which issuer
notified: 25/07/2016
---------------------------------------------------------- ---------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 27%
---------------------------------------------------------- ---------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
---------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- ---------------------------------- ----------------------------------------------------------------------
Number Number Number Number of voting %of voting
of of of shares rights rights(x)
Shares Voting
Rights
------------- ---------------- ---------------- ------------- ------------------------------ -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ ------------- ------------- --------------- ---------- -----------
27.00
GB00BJL5BR07 17,506,222. 17,506,222. 17,514,561 17,514,561 %
--------------- ---------------- ---------------- ------------- ------------- --------------- ---------- -----------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ---------------- ------------------------------- -------------------------- -------------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
---------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date (xvii) Conversion rights instrument rights (xix,
instrument period refers to xx)
(xviii)
------------- ---------------- ---------------- ------------- ---------------------------- ---------------------------
Nominal Delta
------------- ---------------- ---------------- ------------- ---------------------------- ------------ -------------
Total (A+B+C)
---------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------------------- ---------------------------------------------------------
17,514,561 27.00 %
---------------------------------------------------------------- ---------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------
Proxy Voting:
------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ---------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ---------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ---------------
13. Additional information:
------------------------------------------------------------- ---------------
14. Contact name: Akpene Akonou
------------------------------------------------------------- ---------------
15. Contact telephone number: 01865 809024
------------------------------------------------------------- ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFVRVLIILID
(END) Dow Jones Newswires
March 10, 2017 11:37 ET (16:37 GMT)
1 Year 4d Pharma Chart |
1 Month 4d Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
